- Home
- CIFR vs RGEN Comparison
CIFR vs RGEN Comparison
Compare CIFR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIFR
- RGEN
- Stock Information
- Founded
- CIFR 2021
- RGEN 1981
- Country
- CIFR United States
- RGEN United States
- Employees
- CIFR N/A
- RGEN N/A
- Industry
- CIFR Investment Bankers/Brokers/Service
- RGEN Medical/Dental Instruments
- Sector
- CIFR Finance
- RGEN Health Care
- Exchange
- CIFR Nasdaq
- RGEN Nasdaq
- Market Cap
- CIFR 6.7B
- RGEN 6.5B
- IPO Year
- CIFR N/A
- RGEN N/A
- Fundamental
- Price
- CIFR $25.37
- RGEN $146.34
- Analyst Decision
- CIFR Strong Buy
- RGEN Buy
- Analyst Count
- CIFR 11
- RGEN 11
- Target Price
- CIFR $22.85
- RGEN $170.90
- AVG Volume (30 Days)
- CIFR 54.6M
- RGEN 1.1M
- Earning Date
- CIFR 11-03-2025
- RGEN 10-28-2025
- Dividend Yield
- CIFR N/A
- RGEN N/A
- EPS Growth
- CIFR N/A
- RGEN N/A
- EPS
- CIFR N/A
- RGEN 0.03
- Revenue
- CIFR $206,454,000.00
- RGEN $707,890,000.00
- Revenue This Year
- CIFR $77.60
- RGEN $16.79
- Revenue Next Year
- CIFR $73.72
- RGEN $13.58
- P/E Ratio
- CIFR N/A
- RGEN $4,765.07
- Revenue Growth
- CIFR 35.41
- RGEN 11.74
- 52 Week Low
- CIFR $1.86
- RGEN $102.97
- 52 Week High
- CIFR $25.11
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- CIFR 70.68
- RGEN 47.85
- Support Level
- CIFR $20.10
- RGEN $144.18
- Resistance Level
- CIFR $25.11
- RGEN $151.25
- Average True Range (ATR)
- CIFR 2.42
- RGEN 6.72
- MACD
- CIFR 0.22
- RGEN -2.33
- Stochastic Oscillator
- CIFR 93.77
- RGEN 5.75
About CIFR Cipher Mining Inc.
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.